B6I-28Z CAR T cell therapy (The Affiliated Hospital of Xuzhou Medical University)

N/A

Report date: 2024/02/04 17:58:02

Base Information

Drug NameB6I-28Z CAR T cell therapy (The Affiliated Hospital of Xuzhou Medical University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionB-lymphocyte antigen CD19 modulatorsT lymphocyte replacements
TargetsB-lymphocyte antigen CD19
Therapy Area/IndicationsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesThe Affiliated Hospital Of Xuzhou Medical University
China Registration ClassN/A

Develop Information

Active CompaniesThe Affiliated Hospital Of Xuzhou Medical University
Inactive CompaniesN/A
Active IndicationsLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A